Please enable JS

YOU ARE

A STUDY COORDINATOR

Success is when the time to access an innovative treatment is reduced.

CT-SCOUT Solution ToTem4me Solution

Save time in your research activity

Thanks to CT-SCOUTTM you can identify the studies running at your site that could be worth considering for a patient. No need to know or remember all studies criteria: CT-SCOUTTM powerful algorithm will efficiently support you in identifying the potential appropriate studies. CT-SCOUTTM can also help you coordinate the research activities with your colleagues

The CT-SCOUT app

Our web and mobile application exclusively designed for investigators, with its easy-to-use questionnaire.

Why CT-SCOUT app ?

Free up your time

Minimize the administrative burden and redundancy that keeps you and your site staff from focusing on clinical research and patient care.

Involve more patients

Help your patients expand access to clinical trials by integrating CT-SCOUT

Stay Connected

Receive alerts when a patient is identified and track your patients in a decentralized manner

Testimonials

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,

Prof Laurent Peyrin-Biroulet
President, GETAID and ECCO

« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »

Prof Stéphane Nancey
Hepato-gastroenterology department,
Lyon-Sud University Hospital

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,

Prof Laurent Peyrin-Biroulet
President, GETAID and ECCO

LATEST NEWSOUR NEWS >

telemedecine technologies news

Telemedicine Technologies will be at Swiss Biotech Day 2025

April 29, 2025

May 5 & 6 – Basel Telemedicine Technologies is pleased to present its CleanWeb™ eClinical suite, offering flexible, regulatory-compliant solutions tailored to every phase of clinical trials. Our platform includes a wide range of modules, such as eCRF, Randomization & Trial Supply Management, ePRO, eTMF, eConsent, Data Visualization, Vigilance, Imaging, CTMS, and more. We invite […]

READ MORE
telemedecine technologies news

Drug development cost pharma $2.2B per asset in 2024 as GLP-1s drive financial return

April 29, 2025

Fierce Biotech The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as reported in Deloitte’s annual report, “Measuring the return from pharmaceutical innovation.” In 2024, the average […]

READ MORE
telemedecine technologies news

Adopting Flexible Strategies to Combat Capacity Shortages

April 29, 2025

Biopharm International In January 2025, Samsung Biologics signed a six-year, $1.4 billion contract manufacturing agreement with an as-yet undisclosed European pharmaceutical company, with production to take place at Samsung’s manufacturing site in Songdo, South Korea (1). Simultaneously, at the J.P. Morgan Healthcare Conference held in San Francisco, the company announced plans to complete construction of […]

READ MORE